Nanjo et al. further revealed that RBM10 loss-of-function could affect tumor apoptosis by regulating mRNA alternate splicing of the mitochondrial apoptosis regulator Bcl-x, thereby reducing the efficacy of treatment with EGFR-TKIs (Nanjo et al., 2022). Here, EGFR is linked to neoplasm.